Immune thrombocytopenia (ITP) is a bleeding disorder where antibodies and/or T cells lead to enhanced peripheral platelet destruction and reduced bone marrow platelet production. Platelet Preparation and Immunization of CD61 KO mice. Leukoreduced platelets were prepared as previously described. 34 Briefly, blood was drawn by cardiac puncture from anesthetized donor mice into phosphate buffered saline (PBS) containing citrate/phosphate, dextrose, acetate (CPDA buffer).
Introduction
Immune thrombocytopenia (ITP) is an autoimmune bleeding disorder characterized by the presence of plasma antibodies that recognize platelet autoantigens which leads to premature platelet clearance by Fcγ receptor (R) mediated phagocytosis in the reticuloendothelial system (RES). [1] [2] [3] [4] [5] It has also been suggested that the immune response against platelets can effect the bone marrow, leading to megakaryocyte destruction and/or inhibition and impaired platelet production. 6, 7 Of interest, the early thrombocytopenia was in fact due to platelet destruction by CD8+ cytotoxic T cells (CTL) and this was confirmed by other laboratories. 10, 11 We subsequently developed a mouse model of ITP that demonstrated both antibody-and cell-mediated thrombocytopenia where the antibody-mediated form was sensitive to intravenous gammaglobulin (IVIg) treatment whereas the cell-mediated thrombocytopenia was not. 11 Taken together, these results suggest that the immunopathogenesis of ITP is more complex than was originally thought, in that some patients with ITP, particularly chronic ITP, have a cell-mediated form of thrombocytopenia in addition to autoantibody-mediated platelet destruction.
Within the last 6 years, the immunopathologic complexity of ITP has been further supported by many laboratories demonstrating that patients with active ITP have a peripheral deficiency of the CD4+CD25+FoxP+ T helper subset known as T regulatory cells (Tregs). [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] Tregs are thymic derived T cells that are critical in maintaining self tolerance, and genetic deficiencies of this T cell population leads to overwhelming autoimmunity such as the immunodysregulation Platelet Preparation and Immunization of CD61 KO mice. Leukoreduced platelets were prepared as previously described. 34 Briefly, blood was drawn by cardiac puncture from anesthetized donor mice into phosphate buffered saline (PBS) containing citrate/phosphate, dextrose, acetate (CPDA buffer).
The blood was pooled, diluted with PBS-CPDA, centrifuged at 150 x g for 15 minutes and the plateletrich plasma (PRP) was collected. The PRP was washed three times by centrifuging at 450 x g for 18 minutes. The washed platelets were resuspended in PBS-CPDA, counted and their concentration adjusted to 1x10 9 cells/mL. For immunization, BALB/c CD61 KO mice were bled 24 h prior to the first transfusion and then injected with 100 ul (10 8 platelets) CD61+ platelets via the tail vein weekly for 3 weeks. Their sera was tested weekly for the presence of anti-CD61 antibodies by flow cytometry using wild type CD61 platelets and when the titres were found to be >1:1,600, the immune mice were sacrificed by cervical dislocation and their spleens removed, homogenized in RPMI 1640 and washed by centrifugation at 400 x g for 15 minutes. Spleen homogenates were further treated with ACK lysing solution and washed to remove RBC. The splenocytes were then adjusted in PBS to a concentration of 1.5x10 5 cells/mL. Non-transfused (naïve) BALB/c mice were used as source of control splenocytes.
Generation of active ITP. ITP was induced as previously described but with modifications. Briefly, CB.17 SCID mice were first gamma irradiated (2 cGy) and NK cell depleted by an ip infusion Thymus Histology. Mice were sacrificed and thymuses were removed, cleaned of fat and any bronchial lymph nodes and placed in buffered 10% formalin (VWR), pH 6.8-7.2 at room temperature for 2-3 days, followed by auto-processing of the tissue using a Leica TP1020 auto tissue processor (Leica Microsystem, Toronto, ON), and the fixed tissue was embedded in wax (Leica EG1160) and sectioned with a manual microtome (Leica RM 2145). The sections were placed on a glass microscope slide, fixed and stained with hematoxylin-and-eosin (H&E; Leica autostainer XL).
Histological sections were visualized at 40x magnification (numerical aperture, objective lens, 0.75) with an Olympus BX50 upright microscope.
Thymic Function. To determine the ability of thymocytes to affect ITP development, 10 5 of the indicated thymocytes were injected ip on day -5 before the ip administration of splenocytes from CD61 immune mice. Platelet counts were performed at weekly intervals.
Statistical Analysis. Data were analyzed using Student's t test; p<0.05 was considered significant.
Results

Platelet counts and Anti-CD61 Antibody titres.
To ensure that ITP was induced, platelet counts and serum anti-CD61 antibody levels were analyzed.
The initial fall in the platelet count at 7 days ( Figure 1a ) results from the irradiation treatment as previously described. 11 Compared with SCID mice engrafted with splenocytes from naïve mice, For personal use only. on October 24, 2017. by guest www.bloodjournal.org From
Discussion
The immunopathogenesis of ITP has been extensively investigated in the last decade and it appears that one of the major contributing factors in the development of this disorder is a peripheral deficiency of regulatory T cells (Tregs). [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] Tregs are a T cell subset marked by CD4+CD25hi 43, 44 Collectively, these reports suggest that IVIg's protective anti-inflammatory effects are mediated by expanding the suppressive effects of Tregs. This is supported by the data in Figure 4 that shows that development of ITP is delayed by the Treg-laden thymocytes. Perhaps the thymocyte infusions delay antibody production via direct inhibition of immunoglobulin production or inhibition of T helper-B lymphocyte interactions. We are currently studying this.
The mechanism of how Tregs accumulate within the thymus during active ITP is unknown; however, thymic epithelial cells which are the major antigen presenting cells involved in thymic selection of T cells can express the CD61 antigen associated with CD51 to form the vitronectin receptor. [45] [46] [47] It is possible that the transferred anti-CD61 immune splenocytes may damage thymic epithelial cells and cause faulty thymic adhesion or selection processes that lead to Treg retention. Figures 3b and 3d , the proportional data were adjusted for differences in splenic and thymic mass respectively in order to reflect the total lymphocyte content of these organs. Thrombocytopenia at day 7 occurred in all irradiated mice as previously described. 11 The data are 
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